FMP

FMP

Enter

ZURA - Zura Bio Limited

Profile of Zura Bio Limited(ZURA), Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for

photo-url-https://financialmodelingprep.com/image-stock/ZURA.png

Zura Bio Limited

ZURA

NASDAQ

Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California.

5.08 USD

-0.17 (-3.35%)

About

ceo

Mr. Robert Lisicki

sector

Healthcare

industry

Biotechnology

website

https://zurabio.com

exchange

NASDAQ

Description

Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California.

CIK

0001855644

ISIN

N/A

CUSIP

N/A

Address

4225 Executive Square

Phone

858 247 0520

Country

US

Employee

14

IPO Date

Mar 21, 2023

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep